Aromatase inhibitor - PDFSEARCH.IO - Document Search Engine

Aromatase inhibitor
Results: 97

#	Item
11	MSAC application no 1313 Bone mineral density analyses using Dual Energy X-ray Absorptiometry (DXA) in breast cancer patients receiving aromatase inhibitor treatment June 2014 Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2015-04-09 02:11:13 Dual-energy X-ray absorptiometry Radiology AstraZeneca Osteoporosis Bone density Zoledronic acid Denosumab Alendronic acid Tamoxifen Medicine Bisphosphonates Aromatase inhibitors
12	Public Summary Document Application 1313 – Bone mineral density analyses using Dual Energy X-ray Absorptiometry (DXA) in breast cancer patients receiving aromatase inhibitor treatment Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2015-04-15 22:13:38 Radiology Osteoporosis Bone density Aromatase inhibitor Peripheral quantitative computed tomography Denosumab Zoledronic acid Osteopenia Breast cancer treatment Medicine Ribbon symbolism Dual-energy X-ray absorptiometry
13	Microsoft Word - 1313_BMDusingDXAAromataseInhibitor_AttA_FinalAssessmentReport -accessible.docx Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2015-04-15 22:13:39 Dual-energy X-ray absorptiometry Osteoporosis Bone density Aromatase inhibitor Tamoxifen Breast cancer Aromatase Bisphosphonate Vitamin D Medicine Health Radiology
14	SCHEDULE OF PHARMACEUTICAL BENEFITS SUMMARY OF CHANGES EFFECTIVE 1 March 2015 Add to Reading List Source URL: pbs.gov.au Language: English - Date: 2015-02-24 23:29:18 Diols Pyrimidines Rosuvastatin Statins Timolol Capecitabine Aromatase inhibitor Aripiprazole Pharmaceutical drug Chemistry Organic chemistry AstraZeneca
15	1313 Final protocol to guide the assessment of bone mineral density analyses using Dual Energy X-Ray Absorptiometry (DXA) in breast cancer patients receiving aromatase inhibitor treatment July 2013 Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-10-27 00:28:02 Dual-energy X-ray absorptiometry Radiology Osteoporosis Bone density Aromatase inhibitor Peripheral quantitative computed tomography Tamoxifen Osteopenia Denosumab Medicine Bisphosphonates Ribbon symbolism
16	[removed]Consultation decision analytic protocol (DAP) to guide the assessment of bone mineral density analyses using Dual Energy X-Ray Absorptiometry (DXA) in breast cancer patients receiving aromatase inhibitor treatment Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-10-27 00:28:02 Drugs Bisphosphonates Selective estrogen receptor modulators Osteoporosis Dual-energy X-ray absorptiometry Bone density Denosumab Zoledronic acid Alendronic acid Medicine Aromatase inhibitors Osteopathies
17	1313 Consultation decision analytic protocol (DAP) to guide the Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-10-27 00:28:02 Osteoporosis Dual-energy X-ray absorptiometry Bone density Aromatase inhibitor Peripheral quantitative computed tomography Tamoxifen Hormonal therapy Menopause Bone fracture Medicine Health Osteopathies
18	Microsoft Word - Final DAP - App[removed]D13[removed]DOCX Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-10-27 00:28:02 Dual-energy X-ray absorptiometry Aromatase inhibitor Bone density Tamoxifen Peripheral quantitative computed tomography FRAX Osteopenia Menopause Bone fracture Medicine Osteopathies Osteoporosis
19	SCHEDULE OF PHARMACEUTICAL BENEFITS SUMMARY OF CHANGES EFFECTIVE 1 March 2015 Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-02-24 23:29:18 Diols Pyrimidines Rosuvastatin Statins Timolol Capecitabine Aromatase inhibitor Aripiprazole Pharmaceutical drug Chemistry Organic chemistry AstraZeneca
20	References for Substances Tested in the In Vitro ER Binding Assays: Appx D2 - ICCVAM ER Binding BRD (NIH Publication No[removed]) Add to Reading List Source URL: ntp.niehs.nih.gov Language: English - Date: 2015-02-24 12:59:01 Estrogens Nutrients Phenols Intracellular receptors Transcription factors Genistein Phytoestrogens Antiestrogen Aromatase inhibitor Chemistry Biology Endocrine system